TOPLINE:Patients treated for prostate cancer had higher rates of complications, including urinary and sexual issues, than a control group of...
treatment
Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib)...
CHICAGO — Patients who are new users of glucagon-like peptide-1 (GLP-1) receptor agonists have a low absolute risk of thyroid...
Photo: ©iStock/didesign021 Conversation tool helps Veterans make decisions about lung cancer treatment October 25, 2024 By Tristan Horrom VA...
Surgical innovations for breast cancer have led to personalized treatment choices that are more complex than lumpectomy versus mastectomy. (Mayo...
Astellas Pharma Ltd. today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted authorization for PADCEV™ (enfortumab vedotin, an...
